http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4271159-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D505-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-61 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D505-00 |
| filingDate | 1979-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1981-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34c885dd60f88b2b4df487b4759fc0b9 |
| publicationDate | 1981-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4271159-A |
| titleOfInvention | 7-N-Heterocyclyl-2-substituted 1-oxadethia-cephalosporins |
| abstract | Disclosed are antibiotic cephalosporins (I) of the formula: <IMAGE> I Wherein the stylized radical attached to the 7-amino nitrogen of the cephalosporin moiety represents a nitrogen-containing heterocyclic group (mono- or polycyclic); R is, inter alia, hydrogen, alkyl, heterocyclylalkyl, aryl, alkenyl, aralkyl, -NR2, -OR, COOR, CONR2 or CN; Ro is H or CH3; and R2 is H, or loweralkoxyl: Also disclosed are the pharmaceutically acceptable salt and ester derivatives of I; processes for the preparation of such compounds, pharmaceutical compositions comprising such compounds; and methods of treatment comprising administering such compounds and compositions when an antibiotic effect is indicated. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4717722-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0177897-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0177897-A2 |
| priorityDate | 1979-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 342.